KABIVITRUM AB has a total of 221 patent applications. Its first patent ever was published in 1981. It filed its patents most often in EPO (European Patent Office), Sweden and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, foods and drinks and organic fine chemistry are PHARMACIA AB, KABI PHARMACIA AB and CHUNG BONG HYUN.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 49 | |
#2 | Sweden | 41 | |
#3 | WIPO (World Intellectual Property Organization) | 32 | |
#4 | United States | 26 | |
#5 | Australia | 19 | |
#6 | Denmark | 9 | |
#7 | Canada | 8 | |
#8 | Finland | 8 | |
#9 | Norway | 8 | |
#10 | Japan | 5 | |
#11 | Hong Kong | 3 | |
#12 | New Zealand | 3 | |
#13 | Singapore | 2 | |
#14 | Brazil | 1 | |
#15 | Cyprus | 1 | |
#16 | United Kingdom | 1 | |
#17 | Hungary | 1 | |
#18 | Portugal | 1 | |
#19 | USSR (Union of Socialist Soviet Republics) | 1 | |
#20 | Turkey | 1 | |
#21 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Foods and drinks | |
#3 | Organic fine chemistry | |
#4 | Biotechnology | |
#5 | Macromolecular chemistry and polymers | |
#6 | Machines | |
#7 | Medical technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Fodder | |
#4 | Acyclic or carbocyclic compounds | |
#5 | Peptides | |
#6 | Polysaccharides | |
#7 | Foods | |
#8 | Unspecified technologies | |
#9 | Syringes | |
#10 | Heterocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Svahn Carl Magnus Erik | 15 |
#2 | Lindgren Svante | 12 |
#3 | Johansson Rolf Arne | 11 |
#4 | Fryklund Linda | 11 |
#5 | Arielly Salo | 10 |
#6 | Hjertman Birger | 10 |
#7 | Granelli Kristina | 8 |
#8 | Werner Tom | 8 |
#9 | Labbe Jean-Marie | 7 |
#10 | Hanshoff Gunnar | 7 |
Publication | Filing date | Title |
---|---|---|
SE466088B | Pharmaceutical composition for rapidly releasing an active pharmaceutical substance | |
AU6957991A | Chromogenic substrate | |
WO9101135A1 | A nutritive composition and a method for its preparation | |
EP0427904A1 | A process for preparing R(+)-terodiline and salts thereof | |
AU4480889A | A pharmaceutical composition for rapid release of the active component comprising an orderred mixture and a surfactant | |
US5023100A | Fish oil | |
WO9002547A1 | Energy substrate containing hydroxy carboxylic acid | |
AU4189689A | Alternative energy substrate | |
US5093044A | Triglyercide nutrient for humans and animals | |
EP0367734A1 | Energy substrate containing hydroxycarboxylic acid and a glycerol ester | |
EP0349502A1 | Apparatus for washing oriented stoppers | |
EP0364555A1 | Method and apparatus for sorting round objects | |
AU3298089A | Nutrient composition and method for the preparation thereof | |
EP0329632A1 | Apparatus for treating articles with a gaseous and/or liquid medium | |
EP0324725A1 | A pharmaceutical composition | |
US4987726A | Bottle filling and sealing apparatus | |
EP0308386A1 | New medical use | |
GB8819826D0 | Glycosylated igf-1 | |
WO8810312A1 | Determination of components active in proteolysis | |
DK318188D0 | Jewish emulsion for use as a routine contractor |